News & Events about Ac Immune Sa.
AC Immune to Present at the SVB Securities Global Biopharma Conference Lausanne, Switzerland, February 2, 2023 AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that company management will ...
Globe Newswire
2 months ago
Next generation SupraAntigen liposomal vaccine platform augments immunization against pathological targets of Alzheimers diseaseNew data on anti-phospho-Tau vaccines confirm safety, tolerability and immunogenicity of ACI-35 and JACI-35, developed in collaboration with Janssen ...
Globe Newswire
3 months ago
LAUSANNE, Switzerland, Nov. 08, 2022 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that company management will participate in a fireside chat and one-on-one investor meetings ...
Globe Newswire
3 months ago
Announced initiation of dosing of anti-Abeta vaccine ACI-24.060 in the biomarker-based Phase 1b/2 ABATE study in patients with prodromal Alzheimers disease and individuals with Down syndromeReceived regulatory clearance to initiate an adaptive, biomarker-based Phase 2 study of the anti-alpha-...